#1 Clinical Trials Search in Europe

Bronchopulmonary aspergillosis – Diagnostics

Go back

Understanding how allergic bronchopulmonary aspergillosis is diagnosed can help patients and caregivers feel more confident and prepared as they navigate medical appointments and testing. Early and accurate diagnosis plays a vital role in protecting the lungs from long-term damage and keeping symptoms under control.

Introduction: Who Should Seek Diagnostic Testing

Allergic bronchopulmonary aspergillosis, often shortened to ABPA, is a lung condition that develops when the body has an overly strong reaction to a fungus called Aspergillus fumigatus. This fungus is found everywhere in the environment, especially in soil, compost heaps, and fallen leaves, but most people breathe it in without any problems. However, for certain individuals, the immune system treats these fungal spores as serious threats and responds with intense inflammation and other allergic reactions.

People who should consider undergoing diagnostic testing for ABPA are those who already have certain lung conditions. The disease most commonly affects individuals with asthma or cystic fibrosis. If you have asthma that seems to be getting worse despite treatment, or if you notice new symptoms such as coughing up brown or blood-tinged mucus, it is advisable to speak with your doctor about ABPA. Similarly, people with cystic fibrosis who experience unexplained worsening of their breathing or recurring lung problems should be evaluated for this condition.[1][2]

Patients with uncontrolled asthma should be especially alert to the possibility of ABPA. When asthma becomes harder to manage, when symptoms flare up frequently, or when chest X-rays show unusual patterns or infiltrates that do not resolve, these are important signals that further investigation is needed. Additionally, if you develop fever, general weakness, or a feeling of being unwell alongside breathing difficulties, it is time to seek medical attention.[3][4]

Early diagnosis is critical because untreated ABPA can lead to permanent lung damage. Over time, the repeated cycles of inflammation can cause the airways to widen abnormally, a condition known as bronchiectasis, and eventually lead to scarring or fibrosis of lung tissue. These complications can reduce lung function and make patients more vulnerable to infections. By identifying ABPA early, doctors can start treatments that reduce inflammation and prevent these serious outcomes.[6][7]

⚠️ Important
If you have asthma or cystic fibrosis and notice that your symptoms are worsening or not responding to usual treatments, do not wait. Contact your healthcare provider promptly. Early testing for ABPA can help protect your lungs from lasting damage and improve your quality of life.

Classic Diagnostic Methods

Diagnosing ABPA involves a combination of reviewing the patient’s medical history, conducting imaging tests, and performing blood and skin tests. Because ABPA shares symptoms with other lung conditions, doctors use a variety of tools to confirm the diagnosis and rule out other diseases.

Medical History and Physical Examination

The diagnostic process typically begins with a detailed discussion of symptoms and medical history. Your doctor will ask about your asthma or cystic fibrosis history, how well your current treatments are working, and whether you have noticed any new or worsening symptoms. These might include increased wheezing, shortness of breath, coughing with brownish or blood-streaked mucus, fever, or general fatigue. A physical examination often reveals signs of airway obstruction, such as wheezing or prolonged exhalation, which are similar to what is seen during asthma flare-ups.[1][12]

Imaging Tests

Imaging plays a crucial role in diagnosing ABPA. A chest X-ray is often the first step and may show abnormal patterns such as infiltrates, which are areas where the lung tissue appears cloudy or dense. These infiltrates can move or change over time, a feature that is characteristic of ABPA. In many cases, the infiltrates are caused by mucus plugs blocking the airways, leading to collapsed areas of the lung called atelectasis.[1][9]

For a more detailed view, doctors often order a high-resolution computed tomography (CT) scan of the chest. This imaging technique provides a clearer picture of the lungs and can reveal signs of bronchiectasis, which is the abnormal widening of the airways. CT scans can also show mucus-filled airways and other structural changes that help distinguish ABPA from other lung diseases.[6][9]

Allergy Skin Testing

A skin prick test is used to determine whether a patient is allergic to Aspergillus. During this test, a small amount of Aspergillus antigen is injected into the skin of the forearm. If the patient’s blood contains antibodies to the fungus, a hard, red bump will appear at the injection site. A positive skin test indicates that the immune system recognizes and reacts to Aspergillus, which is a key feature of ABPA.[2][9][12]

Blood Tests

Blood tests are essential for confirming ABPA. One of the most important tests measures the level of immunoglobulin E (IgE), a type of antibody that the immune system produces during allergic reactions. Patients with ABPA typically have very high total IgE levels. Doctors also measure IgE antibodies that are specific to Aspergillus fumigatus, which further supports the diagnosis.[1][12]

Another blood test looks for precipitins, which are antibodies that form in response to Aspergillus antigens. The presence of these precipitins, also called circulating antibodies, helps confirm that the immune system is actively responding to the fungus. Additionally, blood tests often reveal an elevated count of eosinophils, a type of white blood cell involved in allergic reactions and inflammation.[1][12]

Sputum Culture

A sputum sample, which is mucus coughed up from the lungs, can be tested to see if Aspergillus is present. The sample is stained with a special dye and examined under a microscope for Aspergillus fibers. It is then placed in a culture dish to see if the fungus grows. A positive sputum culture, along with other test results, supports the diagnosis of ABPA.[9][12]

Diagnostic Criteria

Doctors use a set of criteria to diagnose ABPA, although not every criterion needs to be present in every case. The typical criteria include a history of asthma or cystic fibrosis, a positive skin test or elevated IgE specific to Aspergillus, elevated total IgE levels, the presence of precipitins or other Aspergillus-specific antibodies, abnormal chest X-ray or CT findings, and elevated blood eosinophil counts. In practice, clinicians tailor their diagnostic approach to each patient’s situation.[12]

Diagnostics for Clinical Trial Qualification

When patients are being considered for enrollment in clinical trials for ABPA, the diagnostic requirements can be more stringent and standardized. Clinical trials are research studies designed to test new treatments or better understand the disease, and they often require very specific evidence that a patient has ABPA.

For clinical trial qualification, doctors typically require a confirmed diagnosis based on the established criteria mentioned earlier. This means that patients must demonstrate clear evidence of allergic reaction to Aspergillus through skin testing or blood tests showing high IgE levels. Imaging evidence of bronchiectasis or other lung changes on high-resolution CT scans is often required as well.[1][6]

Blood tests play a central role in trial enrollment. Patients may need to have their total IgE levels measured on more than one occasion to confirm that they remain elevated. Specific IgE to Aspergillus fumigatus and the presence of precipitins are also commonly required. Some trials may also measure eosinophil counts to ensure that patients meet the inflammatory profile associated with ABPA.[1][12]

Sputum cultures or bronchoscopy may be used in clinical trials to confirm the presence of Aspergillus in the airways. In some cases, researchers may want to rule out other conditions that can mimic ABPA, such as invasive aspergillosis or other fungal infections. This is especially important for trials testing antifungal medications or immune-modulating therapies.[9]

Lung function tests, such as spirometry, are often part of the screening process for clinical trials. These tests measure how much air a person can inhale and exhale and how quickly they can do so. Patients with ABPA may show reduced lung function due to airway obstruction or damage. Trial organizers use these measurements to select patients who have a certain level of disease severity and to monitor how well treatments work over time.[1]

Imaging tests, particularly high-resolution CT scans, are crucial for clinical trial enrollment. These scans provide detailed information about the extent of bronchiectasis, mucus plugging, and other lung abnormalities. Some trials may require that patients have evidence of bronchiectasis on imaging, as this indicates more advanced disease that may benefit from experimental treatments.[6]

In addition to diagnostic tests, clinical trials often have strict inclusion and exclusion criteria. For example, patients may need to be stable on their current medications or may be required to have experienced a certain number of flare-ups in the past year. They may also need to avoid certain treatments, such as high-dose steroids or specific antifungal drugs, before entering the trial. These requirements help ensure that the study results are reliable and that the new treatment being tested can be fairly evaluated.[6]

⚠️ Important
If you are interested in participating in a clinical trial for ABPA, speak with your healthcare provider about whether you meet the eligibility criteria. They can help you understand the diagnostic tests required and guide you through the enrollment process. Clinical trials offer access to new therapies and contribute to advancing medical knowledge about this condition.

Prognosis and Survival Rate

Prognosis

The prognosis for allergic bronchopulmonary aspergillosis varies depending on how early the disease is diagnosed and how well it is managed. When ABPA is caught early and treated properly, many patients can achieve remission, a state in which symptoms disappear, asthma is well controlled, and there are no new abnormalities on imaging tests or increases in IgE levels for at least six months. During remission, patients often feel well and can maintain good quality of life.[13][18]

However, ABPA is a chronic condition, and some patients experience relapses, meaning the disease becomes active again after a period of remission. These relapses can occur even with treatment, and patients may need adjustments to their medications or additional therapies to regain control. The frequency and severity of relapses vary from person to person, but ongoing monitoring and close communication with healthcare providers can help manage these episodes.[13]

If ABPA is not diagnosed or treated in time, or if it progresses despite treatment, patients may develop what is called end-stage ABPA. At this point, extensive bronchiectasis and lung fibrosis have occurred, leading to reduced lung function and increased risk of respiratory infections. Patients with advanced disease may also develop complications such as pulmonary hypertension, a condition where blood pressure in the lungs becomes dangerously high. These complications can significantly affect breathing and overall health.[13]

Despite these challenges, it is important to understand that even patients with advanced ABPA can live for many years with stable symptoms if they receive appropriate care. Treatment with corticosteroids and antifungal medications, along with good airway clearance techniques and lifestyle adjustments, can help slow disease progression and improve quality of life. Newer treatments, including biologic medications, are being studied and may offer additional options for managing ABPA in the future.[6][13]

Survival rate

Specific survival rates for ABPA are not commonly reported in the medical literature, largely because the disease varies widely in severity and because many patients live with the condition for many years. The condition itself is not typically considered immediately life-threatening, especially when managed appropriately. Most people with ABPA who receive timely diagnosis and treatment can expect to live for many years, although their quality of life and lung function may be affected by the extent of lung damage.[13]

The risk of complications and reduced survival is higher in patients who develop severe bronchiectasis, pulmonary fibrosis, or respiratory failure. These complications are more likely to occur in patients with uncontrolled or long-standing ABPA. Additionally, a small number of patients with ABPA may develop chronic pulmonary aspergillosis, a more serious fungal infection, particularly if they have cavities in their lungs. However, with close medical follow-up and appropriate interventions, many of these complications can be managed or even prevented.[13][18]

Ongoing Clinical Trials on Bronchopulmonary aspergillosis

  • Study of inhaled liposomal amphotericin B and technetium-99m to assess lung distribution in patients with chronic pulmonary aspergillosis

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

References

https://www.ncbi.nlm.nih.gov/books/NBK542329/

https://www.aaaai.org/conditions-treatments/related-conditions/allergic-bronchopulmonary-aspergillosis

https://www.mayoclinic.org/diseases-conditions/aspergillosis/symptoms-causes/syc-20369619

https://aafa.org/asthma/asthma-triggers-causes/health-conditions-that-trigger-asthma/allergic-bronchopulmonary-aspergillosis/

https://allergyasthmanetwork.org/news/allergic-bronchopulmonary-aspergillosis-abpa/

https://www.nationaljewish.org/conditions/abpa

https://www.columbiadoctors.org/childrens-health/pediatric-specialties/allergy/treatments-conditions/allergic-bronchopulmonary-aspergillosis-abpa

https://www.ncbi.nlm.nih.gov/books/NBK542329/

https://www.mayoclinic.org/diseases-conditions/aspergillosis/diagnosis-treatment/drc-20369623

https://allergyasthmanetwork.org/news/allergic-bronchopulmonary-aspergillosis-abpa/

https://emedicine.medscape.com/article/296052-treatment

https://www.merckmanuals.com/professional/pulmonary-disorders/asthma-and-related-disorders/allergic-bronchopulmonary-aspergillosis-abpa

https://fightfungus.org/living-with-aspergillosis/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6544785/

https://allergyasthmanetwork.org/news/allergic-bronchopulmonary-aspergillosis-abpa/

https://www.cdc.gov/aspergillosis/prevention/index.html

https://www.lung.org/lung-health-diseases/lung-disease-lookup/aspergillosis/treatment

https://aspergillosis.org/understanding-abpa-a-patient-guide-to-managing-allergic-bronchopulmonary-aspergillosis/

https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/aspergillus

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

More information about
Bronchopulmonary aspergillosis:

FAQ

What is the first test my doctor will order if ABPA is suspected?

Your doctor will likely start with a chest X-ray to look for infiltrates or other abnormalities in your lungs. They will also order blood tests to measure your total IgE levels and check for elevated eosinophils. A skin prick test for Aspergillus allergy may also be performed early in the diagnostic process.[1][9]

Can ABPA be diagnosed with just a blood test?

No, ABPA cannot be diagnosed with a blood test alone. While blood tests showing high IgE levels and Aspergillus-specific antibodies are very important, doctors also need imaging tests like a chest X-ray or CT scan and often a positive skin test or sputum culture to confirm the diagnosis.[12]

How is ABPA different from invasive aspergillosis?

ABPA is an allergic reaction to Aspergillus that occurs in people with asthma or cystic fibrosis. The fungus does not invade the lung tissue. Invasive aspergillosis, on the other hand, is a serious infection where Aspergillus invades the lungs and sometimes other organs. It occurs mainly in people with severely weakened immune systems, such as those undergoing chemotherapy or organ transplants.[12]

Do I need a high-resolution CT scan for ABPA diagnosis?

A high-resolution CT scan is very helpful for diagnosing ABPA because it can show bronchiectasis, mucus plugging, and other lung changes in much greater detail than a regular chest X-ray. While not always required, it is often used to confirm the diagnosis and assess the extent of lung damage.[6][9]

Can ABPA go into remission?

Yes, ABPA can go into remission with proper treatment. Remission means that symptoms disappear, asthma is well controlled, and there are no new abnormalities on imaging tests or increases in IgE levels for at least six months. However, relapses can occur, so ongoing monitoring is important.[13]

🎯 Key takeaways

  • • ABPA should be suspected in people with asthma or cystic fibrosis whose symptoms worsen or do not respond to usual treatments.[1]
  • • Early diagnosis is crucial to prevent permanent lung damage such as bronchiectasis and fibrosis.[6]
  • • Diagnosis relies on a combination of medical history, imaging tests, skin testing, and blood tests measuring IgE levels and Aspergillus antibodies.[12]
  • • High-resolution CT scans provide detailed views of lung changes and are especially helpful for diagnosing and monitoring ABPA.[9]
  • • Clinical trials for ABPA may require more stringent and standardized diagnostic criteria, including specific blood tests and imaging findings.[1]
  • • With proper treatment and monitoring, many patients with ABPA can achieve remission and maintain a good quality of life.[13]
  • • Certain genetic factors may influence a person’s susceptibility to developing ABPA.[1]
  • • ABPA is a chronic condition that requires ongoing care, but it is manageable with the right approach.[18]

Connected medications: